More on ATAI
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $7.42 |
|
|||
| Open | $7.41 | ||||
| 52 Wk High | $7.32 | ||||
| 52 Wk Low | $3.30 | ||||
| Day High | $7.45 | ||||
| Day Low | $7.38 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 4,307,160 | ||||
- Oppenheimer Downgrades AtaiBeckley Inc (ATAI) to Perform
- Deutsche Bank Downgrades AtaiBeckley Inc (ATAI) to Hold
- Helus Pharma names ex-Intra-Cellular president as CEO
- A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout
- ATAI Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of AtaiBeckley to Eli Lilly
- ATAI Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of AtaiBeckley to Eli Lilly
- H.C. Wainwright Downgrades AtaiBeckley Inc (ATAI) to Neutral
- Berenberg Downgrades AtaiBeckley Inc (ATAI) to Hold
- TD Cowen Downgrades AtaiBeckley Inc (ATAI) to Hold
- Jefferies Downgrades AtaiBeckley Inc (ATAI) to Hold
Entities mentioned with ATAI
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- IPO | View Related Stories »
- Jefferies & Co | View Related Stories »
- Show More...
